These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24572593)

  • 1. Does infliximab prevent colectomy in acute and chronic active ulcerative colitis?
    Dan-Nielsen S; Wewer V; Paerregaard A; Hansen LF; Nielsen RG; Lange A; Jakobsen C
    J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):768-72. PubMed ID: 24572593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of disease may predict response to infliximab in pediatric ulcerative colitis.
    Mir SA; Nagy-Szakal D; Smith EO; Gilger MA; Kellermayer R
    J Clin Gastroenterol; 2014 Mar; 48(3):248-52. PubMed ID: 24129407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of infliximab in treating patients with ulcerative colitis: experiences from a single medical center in southern China.
    Zhou YL; Xie S; Wang P; Zhang T; Lin MY; Tan JS; Zhi FC; Jiang B; Chen Y
    J Dig Dis; 2014 Sep; 15(9):483-90. PubMed ID: 24828856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab in ulcerative colitis: real-life analysis of factors predicting treatment discontinuation due to lack of response or colectomy: ECIA (ACAD Colitis and Infliximab Study).
    Fernández-Salazar L; Muñoz F; Barrio J; Muñoz C; Pajares R; Rivero M; Prieto V; Legido J; Bouhmidi A; Herranz M; Fernández N; Sánchez-Ocaña R; Joao D; Santos F
    Scand J Gastroenterol; 2016; 51(2):186-95. PubMed ID: 26200929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes of infliximab treatment and predictors of response in 195 patients with ulcerative colitis: a hospital-based cohort study from Korea.
    Seo H; Chang K; Lee SH; Song EM; Kim GU; Seo M; Lee HS; Hwang SW; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK; Park SH
    Scand J Gastroenterol; 2017 Aug; 52(8):857-863. PubMed ID: 28502189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.
    Teisner AS; Ainsworth MA; Brynskov J
    Scand J Gastroenterol; 2010 Dec; 45(12):1457-63. PubMed ID: 20701434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximab.
    Croft A; Walsh A; Doecke J; Cooley R; Howlett M; Radford-Smith G
    Aliment Pharmacol Ther; 2013 Aug; 38(3):294-302. PubMed ID: 23786158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of hospital stay and associated hospital costs with infliximab versus cyclosporine in severe ulcerative colitis.
    Löwenberg M; Duijvis NW; Ponsioen C; van den Brink GR; Fockens P; D'Haens GR
    Eur J Gastroenterol Hepatol; 2014 Nov; 26(11):1240-6. PubMed ID: 25171024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
    Jürgens M; Laubender RP; Hartl F; Weidinger M; Seiderer J; Wagner J; Wetzke M; Beigel F; Pfennig S; Stallhofer J; Schnitzler F; Tillack C; Lohse P; Göke B; Glas J; Ochsenkühn T; Brand S
    Am J Gastroenterol; 2010 Aug; 105(8):1811-9. PubMed ID: 20197757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of infliximab in moderate to severe ulcerative colitis in a latin american referral population.
    Juliao F; Marquez J; Aristizabal N; Yepes C; Zuleta J; Gisbert JP
    Digestion; 2013; 88(4):222-8. PubMed ID: 24281150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
    Jakobovits SL; Jewell DP; Travis SP
    Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab rescue therapy after cyclosporin failure in steroid-refractory ulcerative colitis.
    Mañosa M; López San Román A; Garcia-Planella E; Bastida G; Hinojosa J; Gonzalez-Lama Y; Masnou H; Domènech E
    Digestion; 2009; 80(1):30-5. PubMed ID: 19439969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England.
    Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S
    Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis.
    Lees CW; Heys D; Ho GT; Noble CL; Shand AG; Mowat C; Boulton-Jones R; Williams A; Church N; Satsangi J; Arnott ID;
    Aliment Pharmacol Ther; 2007 Aug; 26(3):411-9. PubMed ID: 17635376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infliximab and complications after colectomy in patients with ulcerative colitis.
    Bregnbak D; Mortensen C; Bendtsen F
    J Crohns Colitis; 2012 Apr; 6(3):281-6. PubMed ID: 22405163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colectomy rate in acute severe ulcerative colitis in the infliximab era.
    Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R
    Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab salvage therapy after failure of ciclosporin in corticosteroid-refractory ulcerative colitis: a multicentre study.
    Chaparro M; Burgueño P; Iglesias E; Panés J; Muñoz F; Bastida G; Castro L; Jiménez C; Mendoza JL; Barreiro-de Acosta M; Senent SG; Gomollón F; Calvet X; García-Planella E; Gómez M; Hernández V; Hinojosa J; Mañosa M; Nyssen OP; Gisbert JP
    Aliment Pharmacol Ther; 2012 Jan; 35(2):275-83. PubMed ID: 22142227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of mucosal healing on long-term outcomes in ulcerative colitis treated with infliximab: a multicenter experience.
    Laharie D; Filippi J; Roblin X; Nancey S; Chevaux JB; Hébuterne X; Flourié B; Capdepont M; Peyrin-Biroulet L
    Aliment Pharmacol Ther; 2013 May; 37(10):998-1004. PubMed ID: 23521659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.